Related Experiment Videos
Immediate prognostic significance of complete atrioventricular block in acute myocardial infarction
Insights
Complete atrioventricular block (CAVB) significantly increases mortality in acute myocardial infarction (AMI) patients, particularly with anterior wall involvement. Clinical factors like QRS width or pacing did not reliably predict survival in these critical cases.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Complete atrioventricular block (CAVB) is a serious complication of acute myocardial infarction (AMI).
- The prognostic significance of CAVB can vary depending on the infarction location and other clinical factors.
Purpose of the Study:
- To evaluate the prognostic impact of CAVB in patients experiencing AMI.
- To determine if clinical parameters can predict outcomes in AMI patients with CAVB.
Main Methods:
- A 7-year observational study of 908 consecutive patients with AMI.
- Analysis of mortality rates in patients with and without CAVB, stratified by infarction location (anterior vs. inferior).
- Evaluation of factors including QRS complex width, escape rhythm frequency, and pacemaker use.
Main Results:
- CAVB was associated with significantly higher in-hospital mortality in both anterior wall AMI (76.9% vs. 10.4%) and inferior wall AMI (20% vs. 6.3%).
- QRS complex width, escape rhythm frequency, and pacemaker therapy did not significantly differentiate survivors from non-survivors.
- In anterior wall AMI, mortality was high regardless of pacing (70% in paced vs. 100% in non-paced).
Conclusions:
- CAVB is a strong independent predictor of mortality in AMI patients.
- Clinical parameters evaluated, including pacemaker use, do not reliably predict survival in AMI patients with CAVB.
- Further research may be needed to identify better prognostic markers and therapeutic strategies for these high-risk patients.
Abstract:
To discern the relative prognostic role of complete atrioventricular block (CAVB) in patients with acute myocardial infarction (AMI), 908 consecutive patients with AMI were studied over a 7-year period. Of the 559 patients with anterior wall AMI, 13 (2.3%) demonstrated CAVB, of whom 10 (76.9%) died in the hospital (vs 10.4% in those without CAVB) (p less than 0.001). In 349 patients with inferior wall AMI, 30 (8.6%) developed CAVB, of whom 6 (20%) died (vs 6.3% in those without CAVB) (p less than 0.01). In anterior wall AMI, all 5 patients with narrow QRS complexes (vs 8/11 with wide QRS complexes) (p = NS) died; in inferior wall AMI, 4/25 with narrow QRS complexes (vs 2/5 with wide QRS complexes) (p = NS) died. The mortality rate of patients with an escape frequency of less than or equal to 50/min did not differ significantly from that of patients with greater than 50/min regardless of the site of infarction or whether a pacemaker was used. In anterior wall AMI, the mortality rate of paced patients was 70% (7/10) compared to 100% (3/3) of non-paced patients (p = NS). In inferior wall AMI, the mortality rate of paced (5/25) and non-paced (1/5) patients was both 20%. Thus, none of the clinical parameters such as escape rhythm, the width of escape QRS complexes and pacemaker therapy discriminated the survivors from the deaths. In anterior wall AMI, episodes of cardiac standstill or bradycardia were of short duration, and pacemaker therapy was only one of the therapies applied.(ABSTRACT TRUNCATED AT 250 WORDS)